Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin 1 in Relapsed NHL and CLL
NCT00002908Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Dec 1996
- Primary completion
- Feb 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bryostatin-1 in non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), sponsored by Barbara Ann Karmanos Cancer Institute. Started Dec 1996; status: completed.
02
Drugs
bryostatin-1
03
Conditions
non-Hodgkin lymphoma (NHL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00002908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002908.